Dedicated Heart Attack Treatment Centre Improves 2-year Survival Rate of Patients with Acute Myocardial Infarction beyond Global Average

Background: Acute ST-Elevation Myocardial Infarction (STEMI) is one of the life-threatening coronary events with sudden cardiac death. It is the most severe clinical presentation of coronary artery disease. The acute STEMI results from an occlusive coronary thrombus at the site of a ruptured atherosclerotic plaque. The aim of the study is to assess 2-year survival rate of patients with acute STEMI received and treatment initiated at the Dedicated Heart Attack Treatment Centre. Materials and Methods: A retrospective observational study was conducted at SKY Hospital & Research Centre, Imphal, India between January 2018 and January 2020 in the population of fifty patients with acute STEMI discharged from the hospital during that period. Results: A rapid and intense diagnosis and treatment of patients with acute STEMI resulted in an improvement of 2-year survival with good quality of life with 92.00% survival rate. Conclusion: The present study of patients with acute ST-Elevation Myocardial Infarction received and treatment started at the Dedicated Heart Attack Centre of SKY Hospital & Research Centre, Imphal, India demonstrated an increase in 2-year survival rate which is higher than many previously published survival rate.